To further delineate stromal immunomodulatory changes with Uro A, PKT mice (n = 10–12/arm) were treated with vehicle or Uro A (20 mg/kg/5x per week), and pancreatic tumors were processed for downstream analysis (Fig. 1C). Here, NPPA is linked to pancreatic neoplasm.